Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinical study proves benefits of joint supplements on canine mobility
Dr Matthew Pead and Dr John Howie at the BSAVA congress.
Dr Matthew Pead and Dr John Howie at the BSAVA congress.

Royal Veterinary College study found "significant" improvements over six week period

The Royal Veterinary College says it has found the first ever clinical proof of the effect of joint supplements on canine mobility.

The college carried out a two and a half year long clinical study.

Monitors originally developed to track wild cat movements in Africa were instead applied to measure the activity of dogs over a six week period.

One set of dogs were given the YUMOVE supplement, and another group a placebo. The group that were given YUMOVE showed statistically significant improvements , the college said.

"This study represents a major step forward in canine mobility”, said Dr Matthew Pead, lead investigator at the RVC.

“It took nine months of careful planning to ensure a robust methodology was developed to provide clear clinical results that veterinary professionals can rely on, and give confidence when recommending joint supplements to dog owners.

"Furthermore, the huge volume of objective activity data will enhance our understanding of the effect of canine osteoarthritis on mobility and activity in the dog’s day to day activities.”

The clinical study was sponsored by Lintbells, the UK based manufacturer of YUMOVE.

“We are very excited by the results of the clinical study” said Lintbells co-founder Dr John Howie.

“From the extensive feedback from owners and vets alike, we already knew the product worked.

"But we wanted to establish independent, rigorous clinical evidence for YUMOVE so that veterinary professionals could recommend the product with confidence, and dog owners knew what to expect from a clinically proven joint supplement in real-life situations.

"There is a great deal of uncertainty and confusion when it comes to joint supplements. This clinical study now provides clarity for clinician and owner alike.

"With an estimated 1.2 million dogs suffering from joint and mobility issues and only approximately 10 to 15 per cent receiving a nutritional supplement, Lintbells believes that providing an affordable, proven product that owners can rely on will uncap the significant market opportunity for veterinary professionals.”

 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
New guidance for antibiotic use in rabbits

New best practice guidance on the responsible use of antibiotics in rabbits has been published by the BSAVA in collaboration with the Rabbit Welfare Association & Fund (RWA&F).

The guidance is free and has been produced to help veterinary practitioners select the most appropriate antibiotic for rabbits. It covers active substance, dose and route of administration all of which are crucial factors when treating rabbits owing to the risk of enterotoxaemia.

For more information and to access the guide, visit the BSAVALibrary.